Literature DB >> 19960273

Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours.

Marco Volante1, Mauro Papotti.   

Abstract

Poorly differentiated thyroid carcinoma (PDTC) was originally described in 1983 but included in the WHO classification of thyroid tumours in the 2004 edition, only. The diagnostic problems encountered in the 5 years of application of the WHO criteria are reviewed here. A long debate is still going on about the nature of PDTC, its morphological diagnostic features, its clinical significance and its optimal therapeutic approach. A consensus conference held in Turin in 2006 confirmed the geographical differences among claimed classical forms of PDTC and suggested a diagnostic algorithm based on the presence of a solid/trabecular/insular growth pattern and of high-grade features, in line with the WHO definition of PDTC, capable to select tumours with a distinct aggressive clinical behaviour. This worked well for PDTC cases from mountain areas (e.g. Northern Italy), where most, if not all, thyroid carcinomas having high-grade features also share a solid/trabecular/insular pattern of growth. However, this scheme might be less easily applicable for American and Japanese cases, possibly due to heterogeneous architectural and cytological features; indeed some Authors still prefer to base their diagnostic work up on the recognition of high-grade features only, including mitotic index and necrosis, irrespective of the growth pattern.

Entities:  

Mesh:

Year:  2010        PMID: 19960273     DOI: 10.1007/s12022-009-9100-4

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  37 in total

1.  BRAF mutations typical of papillary thyroid carcinoma are more frequently detected in undifferentiated than in insular and insular-like poorly differentiated carcinomas.

Authors:  Paula Soares; Vítor Trovisco; Ana Sofia Rocha; Tália Feijão; Ana Paula Rebocho; Elsa Fonseca; Inês Vieira de Castro; José Cameselle-Teijeiro; Manuel Cardoso-Oliveira; Manuel Sobrinho-Simões
Journal:  Virchows Arch       Date:  2004-04-17       Impact factor: 4.064

2.  Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid.

Authors:  M Papotti; B Torchio; L Grassi; A Favero; G Bussolati
Journal:  Am J Surg Pathol       Date:  1996-06       Impact factor: 6.394

3.  Insular carcinoma: a distinct thyroid carcinoma with associated iodine-131 localization.

Authors:  E P Justin; J E Seabold; R A Robinson; W P Walker; N J Gurll; D R Hawes
Journal:  J Nucl Med       Date:  1991-07       Impact factor: 10.057

4.  Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland.

Authors:  S Pilotti; P Collini; L Mariani; M Placucci; I Bongarzone; P Vigneri; S Cipriani; F Falcetta; R Miceli; M A Pierotti; F Rilke
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

5.  N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression.

Authors:  F Basolo; F Pisaturo; L E Pollina; G Fontanini; R Elisei; E Molinaro; P Iacconi; P Miccoli; F Pacini
Journal:  Thyroid       Date:  2000-01       Impact factor: 6.568

6.  E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas.

Authors:  A S Rocha; P Soares; E Fonseca; J Cameselle-Teijeiro; M C Oliveira; M Sobrinho-Simões
Journal:  Histopathology       Date:  2003-06       Impact factor: 5.087

7.  BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.

Authors:  Angela M Costa; Agustín Herrero; Manuel F Fresno; Jonas Heymann; José Antonio Alvarez; Jose Cameselle-Teijeiro; Ginesa García-Rostán
Journal:  Clin Endocrinol (Oxf)       Date:  2007-12-05       Impact factor: 3.478

8.  Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.

Authors:  R Donghi; A Longoni; S Pilotti; P Michieli; G Della Porta; M A Pierotti
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 9.  Problems and controversies in the histopathology of thyroid carcinomas of follicular cell origin.

Authors:  Ronald Ghossein
Journal:  Arch Pathol Lab Med       Date:  2009-05       Impact factor: 5.534

10.  Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients.

Authors:  Marco Volante; Stefania Landolfi; Luigi Chiusa; Nicola Palestini; Manuela Motta; Alessandra Codegone; Bruno Torchio; Mauro G Papotti
Journal:  Cancer       Date:  2004-03-01       Impact factor: 6.860

View more
  19 in total

1.  MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights.

Authors:  Matthias S Dettmer; Aurel Perren; Holger Moch; Paul Komminoth; Yuri E Nikiforov; Marina N Nikiforova
Journal:  J Mol Endocrinol       Date:  2014-03-06       Impact factor: 5.098

Review 2.  Poorly differentiated thyroid carcinoma. Are we there yet?

Authors:  Giovanni Tallini
Journal:  Endocr Pathol       Date:  2011-12       Impact factor: 3.943

3.  Prognostic Impact of Focal Poorly Differentiated Areas in Follicular Differentiated Thyroid Cancer: Is It a Distinct Entity from Poorly Differentiated Thyroid Cancer?

Authors:  Ramakanth Bhargav Panchangam; Pradeep Puthenveetil; Sabaretnam Mayilvaganan
Journal:  Indian J Surg Oncol       Date:  2021-03-20

Review 4.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

5.  Thyroid Angiosarcoma-Rare Case or Hard to Find.

Authors:  Konstantinos Sapalidis; Nikos Kefes; Konstantinos Romanidis; Paul Zarogoulidis; Stelian Pantea; Otilia Constantina Rogoveanu; Ion Rogoveanu; Anastasios Vagionas; Katerina Zarampouka; Kosmas Tsakiridis; Isaac Kesisoglou
Journal:  Curr Health Sci J       Date:  2020-12-31

6.  Poorly differentiated thyroid carcinoma: an incubating entity.

Authors:  Peter M Sadow; William C Faquin
Journal:  Front Endocrinol (Lausanne)       Date:  2012-06-21       Impact factor: 5.555

7.  Analysis of clinical outcome of patients with poorly differentiated thyroid carcinoma.

Authors:  Katsuhiro Tanaka; Hiroshi Sonoo; Wataru Saito; Yusuke Ohta; Toshiro Shimo; Mai Sohda; Yutaka Yamamoto; Junichi Kurebayashi
Journal:  ISRN Endocrinol       Date:  2011-03-29

8.  Propensity score matching analysis of the prognosis for the rare insular subtype of thyroid cancer based on SEER database.

Authors:  Yan Liu; Zeming Liu; Qiuyang Zhao; Teng Hua; Shuqi Chi; Tao Huang; Hongbo Wang
Journal:  Oncotarget       Date:  2017-10-11

9.  Targeted next-generation sequencing of cancer genes in poorly differentiated thyroid cancer.

Authors:  Tiemo S Gerber; Arno Schad; Nils Hartmann; Erik Springer; Ulrich Zechner; Thomas J Musholt
Journal:  Endocr Connect       Date:  2017-11-13       Impact factor: 3.335

10.  Poorly differentiated thyroid carcinoma: a retrospective clinicopathological study.

Authors:  Ghofrane Salhi Cherkaoui; Amal Guensi; Sara Taleb; Malika Ait Idir; Najwa Touil; Rita Benmoussa; Zaineb Baroudi; Nabil Chikhaoui
Journal:  Pan Afr Med J       Date:  2015-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.